Supported by Therapeutic areas, the market for Regenerative Medicine is projected to reach US$24.7 billion by 2017 at a CAGR of 12.5% during the analysis period of 2013-2019.
Global Market Watch:
Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017. Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017, growing at a CAGR of 12.2% for the analysis period 2013-2019 respectively. Skin/Integumentary and Urology together account for approximately 25.97% (2016) of the market are expected to support the Regenerative Medicine Industry going forward. Geographical analysis for Regenerative Medicine in Cardiology shows that the highest Compounded Annual Growth Rate (CAGR) of 18.1% is anticipated from Asia-Pacific region during the analysis period 2013-2019.
Report Focus:
The report ‘Regenerative Medicine – Global Trends, Estimates and Forecasts, 2013-2019’ reviews the latest trends in regenerative medicinewith a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.The study reveals profitable investment strategies for market start-ups,pharmaceutical/biotechnology companies, laboratories,Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyersand many more in preferred locations. The report primarily focuses on:
• Emerging Market Trends
• Advancements in the Technological Space
• Market Demand of The Segments (By-Region)
• Key Growth Areas and Market Size
• Region-Wise Demand Factor
• Key Competitors Edge
• Investment Strategies
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.
The analysis primarily deals by therapeutic area and biological substitutes. Further, the subdivided categories include:
Regenerative Medicine–Segmentation
• Therapeutic Area
o Orthopedics
o Skin/Integumentary
o Cardiology
o Neurology
o Urology
o Other
• Biological Substitutes
o Cells and Biomaterials
o Biomolecules
o Manufacturing Factors and
o Other
The period considered for the regenerative medicinemarket analysis is 2013-2019. The region wise distribution of the market consists of The Americas (USA,Brazil, CanadaandRest of The Americas), Europe (Germany, United Kingdom, France, Switzerland, Spain, The Netherlands,Russiaand Rest of Europe), Asia-Pacific (Japan,South Korea, Australia, China, India and Rest of Asia-Pacific) and Rest of World (Africa and Middle East).The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.
More than 600 market players are identified in regenerative medicineindustry out of which 21 key companies that project improved market activities in the near future are profiled. The report consists of 99 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
